Precision Optics Corporation, Inc. (POCI)
| Market Cap | 45.68M |
| Revenue (ttm) | 24.42M |
| Net Income (ttm) | -6.92M |
| Shares Out | 10.93M |
| EPS (ttm) | -0.92 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,827 |
| Open | 4.220 |
| Previous Close | 4.190 |
| Day's Range | 4.180 - 4.220 |
| 52-Week Range | 3.550 - 6.040 |
| Beta | 0.33 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 14, 2026 |
About POCI
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and milit... [Read more]
Financial Performance
In fiscal year 2025, POCI's revenue was $19.09 million, a decrease of -0.07% compared to the previous year's $19.10 million. Losses were -$5.78 million, 95.8% more than in 2024.
Financial StatementsNews
Precision Optics Corporation Earnings Call Transcript: Q2 2026
Q2 FY2026 revenue hit a record $7.4M, led by aerospace and single-use medical device programs. Gross margin fell to 2.8% due to manufacturing inefficiencies, but operational improvements and strong bookings signal margin recovery and growth in H2. Full-year revenue guidance was raised to $26–$28M.
Precision Optics Schedules Second Quarter of Fiscal Year 2026 Conference Call for February 17, 2026
GARDNER, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical...
Precision Optics Corporation Earnings Call Transcript: Q1 2026
Record Q1 revenue of $6.7M was driven by aerospace and surgical robotics programs, with strong backlog and margin improvements expected as production scales. Fiscal 2026 revenue is projected to exceed $25M, with positive adjusted EBITDA despite a Q1 loss.
Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
GARDNER, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aer...
Precision Optics Announces Product Development Agreement to Develop Custom High-End Borescope for Jet Engines
GARDNER, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aer...
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
GARDNER, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aer...
Precision Optics Schedules First Quarter of Fiscal Year 2026 Conference Call for November 13, 2025
GARDNER, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical...
Precision Optics Corporation Transcript: Lytham Partners Fall 2025 Investor Conference
Precision Optics is experiencing a pivotal shift as major programs transition from development to manufacturing, driving a projected 30%+ revenue increase to $25 million in fiscal 2026. Manufacturing growth, a record $18 million backlog, and operational investments are expected to restore margins and positive EBITDA.
Precision Optics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
GARDNER, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medica...
Precision Optics Corporation Earnings Call Transcript: Q4 2025
Record Q4 revenue and a strong production backlog set the stage for over 30% revenue growth and a gross margin rebound to 30% in fiscal 2026, driven by aerospace and medical programs. Operational investments and new leadership aim to support scaling and profitability.
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Conference Call Scheduled for today, September 29, 2025, at 5:00pm ET Company introduces fiscal year 2026 Revenue and Adjusted EBITDA guidance Company appoints new Chief Operating Officer GARDNER, Mas...
Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025
GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medica...
Precision Optics Corporation Transcript: Lytham Partners Consumer & Technology Summit
The company leverages proprietary micro-optics, ultra-precision, and digital imaging technologies to drive growth in medical devices and defense/aerospace, with a focus on single-use endoscopes and robust customer retention. Recent manufacturing expansion and the Unity platform aim to accelerate product development and support increasing demand.
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical...
LaCroix Precision Optics Expands in Batesville, Arkansas, Creating 107 New Jobs
BATESVILLE, Ark., June 05, 2025 (GLOBE NEWSWIRE) -- LaCroix Precision Optics announced that it will be expanding its manufacturing operations in Batesville, Arkansas, creating 107 new jobs over five y...
Precision Optics Expands Facilities to Meet Growing Backlog
Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows for expansion of production capabilities in Gardner, MA to meet increased backlog GARDNER, Mass. ...
Precision Optics Corporation Transcript: Lytham Partners Spring 2025 Investor Conference
The company is at an inflection point, shifting from product development to high-volume manufacturing, driven by major programs in single-use medical devices and aerospace. Revenue growth is expected to accelerate as new programs enter production, supported by expanded facilities and a robust pipeline.
Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GARDNER, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical ...
Precision Optics Corporation Earnings Call Transcript: Q3 2025
Q3 saw lower revenue and margins due to production issues, but backlog and demand remain strong. The Unity platform launch and a major aerospace contract support a positive Q4 outlook, with revenue expected to rebound and adjusted EBITDA turning positive.
Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aero...
Precision Optics Market Global Forecast Report to 2030: Cumulative Impact of United States Tariffs
Trends show a shift toward sophisticated optical systems in automotive, electronics, and defense sectors. Trends show a shift toward sophisticated optical systems in automotive, electronics, and defen...
Precision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025
GARDNER, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical ...
Precision Optics Corporation Transcript: Planet MicroCap Showcase: VEGAS 2025
Proprietary Micro-Optics and imaging technologies drive growth in medical and defense markets, with two major programs recently entering production and a new Unity platform accelerating development. Revenue and backlog are set to increase, supported by expanded facilities and strategic partnerships.
Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
GARDNER, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ae...
Precision Optics Corporation Transcript: Lytham Partners 2025 Industrials & Basic Materials Investor Summit
Precision Optics is leveraging proprietary micro-optics and digital imaging to drive growth in medical and defense markets, with a focus on single-use endoscopes and the new Unity platform to accelerate development. Major production orders and a robust pipeline position the company for continued expansion.